CDER’s Office of Pharmaceutical Quality’s Use of Remote Interactive Evaluations

Throughout the COVID-19 public health emergency, CDER’s Office of Pharmaceutical Quality has been using all tools at our disposal to continue evaluating facilities to assure drug quality. One of these tools is remote interactive evaluation using livestreamed video of operations and remote, live interactions with operators. https://www.fda.gov/news-events/press...